Stages I-IIIA Lung Cancer - Non-Small Cell


Precision Medicine Guides NSCLC Cancer Treatment: All Patients Should Undergo Molecular Testing (October 27, 2016)

Lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States, non-small cell lung cancer (NSCLC) accounts for 75–80% of all lung cancers. Although progress has been... Continue Reading

Tecentriq® Improves NSCLC Survival Compared to Chemotherapy Regardless of PD-L1 Status (October 25, 2016)

Tecentriq® (atezolizumab) improves the outcomes of individuals with advanced non-small cell lung cancer (NSCLC) according to the results of a pivotal clinical trial presented at the European Society of... Continue Reading

Patient Panel on Non-Small Cell Lung Cancer Addresses Key Issues (October 14, 2016)

Voices of Value Speak Up: Non-Small Cell Lung Cancer is the first part of a national six-event program presented by Patients Rising and Aimed Alliance. Where is the patient in the national conversation... Continue Reading

Lung Cancer Advances: Precision Medicine and Immunotherapy Make a Difference (March 1, 2016)

Precision medicine continues to impact the lives of lung cancer patients with research into genomics and genetics leading to unprecedented progress in improving outcomes. Tailored treatments have emerged... Continue Reading

16th World Conference on Lung Cancer Expected to Highlight Advances in Precision Medicine (September 6, 2015)

Today, September 6, the 16th World Conference on Lung Cancer (WCLC) begins in Denver, Colorado. The WCLC is the world’s largest meeting dedicated to lung cancer and other thoracic malignancies. More... Continue Reading

EGFR Testing in Advanced Lung Cancer Appears Underutilized (April 28, 2015)

The results of a recent survey suggest that nearly a quarter of advanced lung cancer patients fail to receive epidermal growth factor receptor (EGFR) testing before starting treatment. The recent development... Continue Reading

References (February 6, 2015)

1 The International Adjuvant Lung Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected Non-Small Cell Lung Cancer. New England Journal of Medicine. 2004;350:351-360. 2... Continue Reading

Radiation Therapy (February 6, 2015)

Some patients with NSCLC are not able to undergo the surgery to remove their cancer. Advanced age and other medical conditions such as heart disease and diminished lung capacity make it more difficult... Continue Reading

Non-Small Cell Lung Cancer: The ALCHEMIST Lung Cancer Trials (January 14, 2015)

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for... Continue Reading

Year in Review: Research News from 2014 in Non-Small Cell Lung Cancer (January 9, 2015)

After several years of developments in lung cancer treatment, more-targeted and more-individualized treatment for non–small cell lung cancer became a reality. Results from studies evaluating ALK-inhibitors... Continue Reading

Innovative Clinical Trials for Lung Cancer Currently Underway (January 7, 2015)

The cancer research community is moving forward in its efforts find more effective treatment for patients with lung cancer. Current clinical trials are taking innovative approaches to how therapies for... Continue Reading

Strategies to Improve Non Small Cell Lung Cancer Treatment (December 12, 2014)

The development of more effective treatment for NSCLC requires that new and innovative therapies be evaluated with cancer patients. Future progress in treatment will result from the continued evaluation... Continue Reading

Radiation Therapy (December 12, 2014)

Some patients with lung cancer are not able to undergo the surgery to remove their cancer. Advanced age and other medical conditions such as heart disease and diminished lung capacity make it more difficult... Continue Reading

References for Non Small Cell Lung Cancer (December 12, 2014)

1 The International Adjuvant Lung Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected Non-Small Cell Lung Cancer. New England Journal of Medicine. 2004;350:351-360. 2 Kato... Continue Reading

References for Non Small Cell Lung Cancer (December 8, 2014)

1 The International Adjuvant Lung Trial Collaborative Group. Cisplatin-based adjuvant chemotherapy in patients with completely resected Non-Small Cell Lung Cancer. New England Journal of Medicine. 2004;350:351-360. 2... Continue Reading

Radiation (December 8, 2014)

Some patients with lung cancer are not able to undergo the surgery to remove their cancer. Advanced age and other medical conditions such as heart disease and diminished lung capacity make it more difficult... Continue Reading

Xalkori™ (crizotinib) Targeted Therapy More Effective Than Chemotherapy for Treatment of Lung Cancer (December 6, 2014)

A new drug Xalkori™ (crizotinib) is more beneficial than chemotherapy for certain individuals with lung cancer according to new research published in the New England Journal of Medicine. Lung cancer... Continue Reading

Recent Treatment Advancements in Lung Cancer (December 5, 2014)

By Christina S. Baik, MD, MPH Assistant Professor, University of Washington School of Medicine Assistant Member, Clinical Research Division, Fred Hutchinson Cancer Research Center Facing a lung cancer... Continue Reading

Next Page »

Sign up for the CancerConnect newsletter

Sign up for our newsletter and receive the latest news and updates about specific types of cancer.

  Close |  Please don't show me this again

Facebook Twitter RSS